Ex vivoexpanded human circulating Vδ1 γδT cells exhibit favorable therapeutic potential for colon cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ex vivoexpanded human circulating Vδ1 γδT cells exhibit favorable therapeutic potential for colon cancer
Authors
Keywords
-
Journal
OncoImmunology
Volume 4, Issue 3, Pages e992749
Publisher
Informa UK Limited
Online
2015-01-23
DOI
10.4161/2162402x.2014.992749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- γδT Cells: First Line of Defense and Beyond
- (2014) Yueh-hsiu Chien et al. Annual Review of Immunology
- Activating and Propagating Polyclonal Gamma Delta T Cells with Broad Specificity for Malignancies
- (2014) D. C. Deniger et al. CLINICAL CANCER RESEARCH
- Neuroblastoma Killing Properties of V 2 and V 2-Negative T Cells Following Expansion by Artificial Antigen-Presenting Cells
- (2014) J. P. H. Fisher et al. CLINICAL CANCER RESEARCH
- γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
- (2014) Pin Wu et al. IMMUNITY
- Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells
- (2013) Christian Peters et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Potential regulatory role of in vitro-expanded Vδ1 T cells from human peripheral blood
- (2013) Fang Hua et al. IMMUNOLOGIC RESEARCH
- Tumor-Derived Regulatory T Cells Suppress Innate and Adaptive Immunity through the Induction of Immunosenescence
- (2013) J. Ye et al. JOURNAL OF IMMUNOLOGY
- IL-7 Produced by Thymic Epithelial Cells Plays a Major Role in the Development of Thymocytes and TCR + Intraepithelial Lymphocytes
- (2013) S. Shitara et al. JOURNAL OF IMMUNOLOGY
- T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion
- (2013) Daniel T Utzschneider et al. NATURE IMMUNOLOGY
- CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vδ1+ γδ T Cells
- (2013) Andrea Knight et al. PLoS One
- Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside
- (2012) Mounia S. Braza et al. BRITISH JOURNAL OF HAEMATOLOGY
- Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI
- (2012) Gabrielle M. Siegers et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- In Vivo Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Trigger V 9V 2 T-cell Antitumor Cytotoxicity through ICAM-1 Engagement
- (2012) I. Benzaid et al. CLINICAL CANCER RESEARCH
- Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells
- (2012) Andrea Knight et al. CYTOTHERAPY
- Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy
- (2012) Volker Kunzmann et al. JOURNAL OF IMMUNOTHERAPY
- Zoledronate Sensitizes Neuroblastoma-derived Tumor-initiating Cells to Cytolysis Mediated by Human γδ T Cells
- (2012) Nobuhiro Nishio et al. JOURNAL OF IMMUNOTHERAPY
- Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes
- (2012) Marco Donia et al. OncoImmunology
- Differentiation of human peripheral blood V 1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells
- (2011) D. V. Correia et al. BLOOD
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
- (2011) A J Nicol et al. BRITISH JOURNAL OF CANCER
- Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside
- (2011) Barbara Castella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells
- (2011) Gabrielle M. Siegers et al. CYTOTHERAPY
- Adoptive immunotherapy of cancer using ex vivo expanded human γδ T cells: A new approach
- (2010) Pouneh Dokouhaki et al. CANCER LETTERS
- Targeting T Lymphocytes for Cancer Immunotherapy: From Novel Mechanistic Insight to Clinical Application
- (2010) A. Q. Gomes et al. CANCER RESEARCH
- Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+ primary colon cancer cells
- (2010) Y. K. Wang et al. CARCINOGENESIS
- Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors
- (2010) Atsutaka Noguchi et al. CYTOTHERAPY
- Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens
- (2010) Masashi Iwasaki et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Antitumor Activity of T Cells Reactive against Cytomegalovirus-Infected Cells in a Mouse Xenograft Tumor Model
- (2009) C. Devaud et al. CANCER RESEARCH
- Efficient Killing of Human Colon Cancer Stem Cells by T Lymphocytes
- (2009) M. Todaro et al. JOURNAL OF IMMUNOLOGY
- Zoledronate facilitates large-scale ex vivo expansion of functional γδ T cells from cancer patients for use in adoptive immunotherapy*
- (2008) M. Kondo et al. CYTOTHERAPY
- Immune Response of Human Propagated γδ-T-Cells to Neuroblastoma Recommend the Vδ1+ Subset for γδ-T-cell–based Immunotherapy
- (2008) Karin Schilbach et al. JOURNAL OF IMMUNOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started